scispace - formally typeset
R

Ryoichi Ochiai

Researcher at Toho University

Publications -  87
Citations -  1502

Ryoichi Ochiai is an academic researcher from Toho University. The author has contributed to research in topics: Sevoflurane & Cardiac output. The author has an hindex of 22, co-authored 85 publications receiving 1375 citations. Previous affiliations of Ryoichi Ochiai include Keio University.

Papers
More filters
Journal ArticleDOI

Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.

TL;DR: This study demonstrated that the risk of TOFR <0.9 after tracheal extubation after sugammadex remains as high as 9.4% in a clinical setting in which neuromuscular monitoring (objective or subjective) was not used.
Journal ArticleDOI

Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.

TL;DR: Based on the observed occurrence of compound heterozygous state, the prevalence of a possibly predisposing phenotype in the Japanese population might be as high as 1 in 2,000 people.
Journal ArticleDOI

Comparison of early postoperative quality of life in minimally invasive versus conventional valve surgery.

TL;DR: Although longer aortic clamp and cardiopulmonary bypass times remain a problem in MICS procedures, the results suggest that MICS facilitates earlier recovery of daily activities and provides improved quality of life in the early postoperative period.
Journal ArticleDOI

Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans.

TL;DR: It is concluded that lengthy sevoflurane anesthesia created serum inorganic fluoride concentrations that could influence renal function, although nephrotoxicity was not demonstrated in the biochemical study.
Journal ArticleDOI

The Japanese guidelines for the management of sepsis.

TL;DR: This guideline was developed on the basis of evidence-based medicine and focuses on unique treatments in Japan that have not been included in the Surviving Sepsis Campaign guidelines (SSCG), as well as treatments that are viewed differently in Japan and in Western countries.